Elucidata Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 180

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Elucidata General Information

Description

Developer of a data analytics platform designed to analyze omics datasets to understand the molecular basis of cellular phenotypes. The company's platform can process, analyze, and visualize large omics data across metabolic, genomics, transcriptomic, and proteomics, among others, to transform decision-making processes in drug research and development, enabling scientists and doctors to discover treatments for diseases efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2261 Market Street
  • Suite 10296
  • San Francisco, CA 94114
  • United States
+1 (773)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 2261 Market Street
  • Suite 10296
  • San Francisco, CA 94114
  • United States
+1 (773)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elucidata Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-May-2026 Completed Generating Revenue
3. Later Stage VC (Series A) 21-Sep-2022 Completed Generating Revenue
2. Seed Round 28-Jan-2021 $5M $6.7M Completed Generating Revenue
1. Seed Round 09-May-2018 $1.7M $1.7M Completed Generating Revenue
To view Elucidata’s complete valuation and funding history, request access »

Elucidata Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Pre-Series A2
Pre-Series A1 526,689 $0.000100 $2 $2 1x $2 4%
Seed 800,583 $0.000100 $2.12 $2.12 1x $2.12 6.08%
To view Elucidata’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Elucidata Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a data analytics platform designed to analyze omics datasets to understand the molecular basis of cellular
Discovery Tools (Healthcare)
San Francisco, CA
180 As of 2026

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elucidata Competitors (1)

One of Elucidata’s competitors is DNAnexus, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAnexus Venture Capital-Backed San Francisco, CA
You’re viewing 1 of 1 competitors. Get the full list »

Elucidata Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Elucidata Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anthropic AWS Agentic AI Accelerator Accelerator/Incubator
Eight Roads Corporate Venture Capital Minority
F-Prime Venture Capital Minority
TiE SoCal Angels Angel Group Minority
Anvaya Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Elucidata FAQs

  • When was Elucidata founded?

    Elucidata was founded in 2015.

  • Where is Elucidata headquartered?

    Elucidata is headquartered in San Francisco, CA.

  • What is the size of Elucidata?

    Elucidata has 180 total employees.

  • What industry is Elucidata in?

    Elucidata’s primary industry is Discovery Tools (Healthcare).

  • Is Elucidata a private or public company?

    Elucidata is a Private company.

  • What is Elucidata’s current revenue?

    The current revenue for Elucidata is .

  • How much funding has Elucidata raised over time?

    Elucidata has raised $22.7M.

  • Who are Elucidata’s investors?

    Anthropic AWS Agentic AI Accelerator, Eight Roads, F-Prime, TiE SoCal Angels, and Anvaya Ventures are 5 of 7 investors who have invested in Elucidata.

  • Who are Elucidata’s competitors?

    DNAnexus is a competitor of Elucidata.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process